Generic Co. Lobs Antitrust Suit To Access Brand-Name Meds

Law360, New York (April 1, 2013, 6:33 PM EDT) -- Generic-drug maker Accord Healthcare Inc. on Monday sued Acorda Therapeutics Inc. in Florida federal court for allegedly trying to stave off competition by refusing to sell samples of multiple sclerosis drug Ampyra to rival companies looking to introduce a lower-cost version of the medicine.

Accord, a unit of Indian drugmaker Intas Pharmaceuticals Ltd., is aiming to apply for U.S. Food and Drug Administration approval in January and says it needs to acquire samples by next month if it’s going to meet that target.

No generic version...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.